Granules India Limited Sertraline Export Data — India (DGFT 2022–2026)

Name: Granules India Limited Sertraline Export Records India — #7 Exporter, 155 Shipments, $7.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Sertraline

India Pharmaceutical Trade Intelligence

$560.5M218 Suppliers88 CountriesHS 30049099

ExportsIndia → UNITED STATES60.3%India → BELGIUM10.4%

ImportsUNITED STATES → India$192.5K GERMANY → India$14.4K

#1 Supplier: CIPLA LIMITED #1 Buyer: CIPLA USA

Granules India Limited — Sertraline Exporter #7 | $7.8M Trade Value | TransData Nexus | TransData Nexus

Granules India Limited — Sertraline Exporter Profile

Indian Pharmaceutical Exporter · #7 for Sertraline · $7.8M export value · DGFT Verified

Granules India Limited is the #7 Indian exporter of Sertraline with $7.8M in export value and 155 verified shipments. Granules India Limited holds a 1.4% market share in Sertraline exports across 1 countries. The company exports 20 pharmaceutical products worth $412.3M across 9 therapeutic categories.

Granules India Limited — Sertraline Export Profile: Buyers & Destinations

Granules India Limited Sertraline export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Sertraline?

Country	Value	Shipments	Share
UNITED STATES	$44.9M	897	28.6%
MALTA	$27.1M	541	17.3%
BELGIUM	$19.1M	383	12.2%
UNITED KINGDOM	$12.8M	342

Who Are the Top Buyers of Sertraline from India?

Buyer	Country	Value	Orders
CIPLA USA INC UPS SUPPLY CHAIN SOLU	UNITED STATES	$17.1M	341
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$14.1M	281
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$11.8M	237
CIPLA USA INC UPS SUPPLY CHAIN SOL	UNITED STATES	$5.9M	118
ZAO TORRENTPHARMA	RUSSIA	$4.2M	83
GRANULES PHARMACEUTICALS, INC	UNITED STATES	$3.2M	64
ORION CORPORATION,	FINLAND	$2.9M	57
KYOWA PHARMACEUTICAL IND.CO.,LTD.,	JAPAN	$2.3M	45
XXROBXXDO XXARMXXUSAXX INXX	UNITED STATES	$1.1M	21
AUROBINDO PHARMA USA INC	UNITED STATES	$850.0K	17

India's Sertraline is purchased by 553 buyers worldwide. The top buyer is CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES), followed by YUSEN LOGISTICS BENELUX BELGIUM and APL SWIFT SERVICES (MALTA) LTD.,.

How Does Granules India Limited Compare to Nearest Sertraline Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	CIPLA LIMITED	$27.5M	550	2	$50.0K
6	TORRENT PHARMACEUTICALS LTD	$10.7M	232	8	$46.2K
7	GRANULES INDIA LIMITED ★	$7.8M	155	1	$50.0K
9	AUROBINDO PHARMA LIMITED	$6.6M	247	16	$26.9K
8	IPCA LABORATORIES LIMITED	$6.2M	123	10	$50.0K

Granules India Limited ranks #7 among 218 Indian Sertraline exporters. Average shipment value of $50.0K compared to the market average of $691.9K. The closest competitors by value are CIPLA LIMITED and TORRENT PHARMACEUTICALS LTD.

Which Indian Ports Ship Sertraline Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	592	11.4%
SAHAR AIR	498	9.6%
NHAVA SHEVA SEA (INNSA1)	382	7.4%
DHANNAD ICD	268	5.2%
HYDERABAD ICD	184	3.6%
DHANNAD ICD (INDHA6)	177	3.4%
DELHI AIR	173	3.3%
VIZAG SEA (INVTZ1)	172	3.3%

Geopolitical & Trade Policy Impact on Granules India Limited's Sertraline Exports

Granules India's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, compelling maritime carriers to reroute via the Cape of Good Hope. This has resulted in increased lead times and freight costs, posing challenges for time-sensitive pharmaceutical shipments. To mitigate these risks, Granules India is leveraging its multi-site manufacturing capabilities and strategic inventory positioning. (pharmaceuticalcommerce.com)

The U.S.-China trade tensions have created opportunities for Indian pharmaceutical exporters like Granules India, as global buyers seek to diversify their supply chains. However, compliance with evolving U.S. pharmaceutical import policies remains crucial. In the European Union, the implementation of the Falsified Medicines Directive necessitates stringent serialization and traceability measures. Granules India's proactive approach to regulatory compliance positions it favorably to navigate these complexities and maintain its export momentum.

Granules India Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Granules India, given its extensive export operations. The company's Gagillapur facility in Telangana received a warning letter from the U.S. Food and Drug Administration (FDA) in February 2025, following an inspection that identified issues related to equipment maintenance and contamination control. In response, Granules India implemented comprehensive corrective and preventive actions, including engaging independent consultants and enhancing cleaning protocols. The company has been providing regular updates to the FDA and is prepared for re-inspection to demonstrate compliance. (moneycontrol.com)

Conversely, Granules India's U.S.-based packaging facility in Virginia successfully cleared an FDA inspection in December 2025 with zero observations, reflecting the company's commitment to quality and regulatory excellence. (pharma.economictimes.indiatimes.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Sertraline shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Granules India Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 88+ countries, 553+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Sertraline

Sertraline

Granules India Limited — Sertraline Exporter Profile

Granules India Limited — Sertraline Export Profile: Buyers & Destinations

Where Does India Export Sertraline?

Who Are the Top Buyers of Sertraline from India?

What Is India's Total Sertraline Export Value and How Much Does Granules India Limited Contribute?

What Is the Average Shipment Value for Granules India Limited's Sertraline Exports?

How Does Granules India Limited Compare to Other Indian Sertraline Exporters?

Regulatory Requirements: Exporting Sertraline to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Granules India Limited Compare to Nearest Sertraline Exporters?

Which Indian Ports Ship Sertraline Exports?

What Other CNS & Psychiatric Products Does Granules India Limited Export?

Geopolitical & Trade Policy Impact on Granules India Limited's Sertraline Exports

Granules India Limited — Regulatory Compliance & Quality Standards

About Granules India Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Sertraline Export Data from Granules India Limited

Sertraline Stats

Company Overview

Top Products by Granules India Limited

Related Analysis

Need Detailed Export Data?

Data Source